Profile
Frank Perabo is currently Chief Executive Officer at Tachyon Therapeutics, Inc. since 2020.
Dr. Perabo is Associate Professor at the University of Bonn.
Dr. Perabo is Vice President-Clinical Development at MacroGenics, Inc. Formerly, Dr. Perabo was Executive Director-Oncology at Astellas Pharma Global Development, Inc. from 2008 to 2011.
Dr. Perabo was Chief Medical Officer & EVP-Clinical Development at ESSA Pharma, Inc. from 2014 to 2018.
Dr. Perabo completed undergraduate education at Hochschule München.
Frank Perabo active positions
| Companies | Position | Start |
|---|---|---|
| MACROGENICS, INC. | Chief Tech/Sci/R&D Officer | - |
University of Bonn
University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Frank Perabo
| Companies | Position | End |
|---|---|---|
| ESSA PHARMA INC. | Chief Tech/Sci/R&D Officer | 2018-01-30 |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 2011-05-31 |
Training of Frank Perabo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
MacroGenics, Inc.
MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
University of Bonn
University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hochschule München
Hochschule München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ESSA Pharma, Inc.
ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
- Stock Market
- Insiders
- Frank Perabo
















